English (international)
Eesti
Български
Deutsch
Français
Español (Latinoamérica)
Polski
Magyar
Română
Lonza Group AG
Închisă
552 -0.29
Rezumat
Modificarea prețului
24h
Minim
551.4
Maxim
556
Venit | 244M |
|---|---|
Vânzări | -582M 3.1B |
P/E Medie Sector | 26.67 |
EPS | 4.61 |
Marjă de profit | 6.705 |
Capitalizare de piață | -144M 40B |
|---|---|
Deschiderea anterioară | 552.29 |
Închiderea anterioară | 552 |
Sentimentul știrilor
By Acuity
100%
0%
Lonza Group AG Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Știri relevante
Lonza Group AG Așteptări
Sentiment
By Acuity
Sentimentul știrilor
Evidențe foarte puternice de scădere
Volatilitate
Sub medie
Volumul știrilor (RCV)
Peste medie
Date financiare
Cheltuieli de exploatare
Profit pre-impozitare
Vânzări
Costul vânzărilor
Profit brut din vânzări
Cheltuieli cu dobânzile pe datorie
EBITDA
Profit operațional
$
Despre Lonza Group AG
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.